Chapter 12. Retinoids in Clinical Use

  1. Prof. Dr. Eckhard Ottow2 and
  2. Dr. Hilmar Weinmann3
  1. Vincent C. O. Njar

Published Online: 19 DEC 2008

DOI: 10.1002/9783527623297.ch12

Nuclear Receptors as Drug Targets

Nuclear Receptors as Drug Targets

How to Cite

Njar, V. C. O. (2008) Retinoids in Clinical Use, in Nuclear Receptors as Drug Targets (eds E. Ottow and H. Weinmann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527623297.ch12

Editor Information

  1. 2

    Bayer Schering Pharma AG, Medicinal Chemistry (S106/345), Müllerstrasse 178, 13342 Berlin, Germany

  2. 3

    Bayer Schering Pharma AG, Medicinal Chemistry (S106/048A), Müllerstrasse 178, 13342 Berlin, Germany

Author Information

  1. University of Maryland, School of Medicine, Department of Pharmacology and Experimental Therapeutics, 655 W. Baltimore Street, Baltimore, MD 21201-1559, USA

Publication History

  1. Published Online: 19 DEC 2008
  2. Published Print: 20 AUG 2008

Book Series:

  1. Methods and Principles in Medicinal Chemistry

Book Series Editors:

  1. Prof. Dr. Raimund Mannhold4,
  2. Prof. Dr. Hugo Kubinyi5 and
  3. Prof. Dr. Gerd Folkers6

Series Editor Information

  1. 4

    Molecular Drug Research Group, Heinrich-Heine-Universität, Universitätsstrasse 1, 40225 Düsseldorf, Germany

  2. 5

    Donnersbergerstrasse 9, 67256 Weisenheim am Sand, Germany

  3. 6

    Collegium Helveticum, STW/ETH Zurich, 8092 Zurich, Switzerland

ISBN Information

Print ISBN: 9783527318728

Online ISBN: 9783527623297

SEARCH

Keywords:

  • retinoids

Summary

This chapter contains sections titled:

  • Introduction

  • Mechanism of Action of Retinoids and Retinoic Acids

  • Retinoids and Rexinoids in the Clinic

  • Development of New Retinoids/Rexinoids and the Future for Retinoid-based Therapies

  • Conclusions

  • References